Introduction
============

Cardiovascular disease is the leading cause of death in Brazil ([@b14]). Acute limb ischemia is responsible for a high proportion of morbidity and mortality attributable to cardiovascular disease. It is caused by thrombosis or embolism from the heart or major arterial branches ([@b9]; [@b17]; [@b15]). Surgical revascularization or endovascular therapy is a major determinant of not only limb but also life survival in such a population of patients ([@b10]). The results of the surgical revascularization by thromboembolectomy or bypass may be influenced by several prognostic factors: eg, antecedent cardiovascular risk factors, duration and presentation of the acute episode, surgical technique, and location of occlusion, to mention a few ([@b17]; [@b18]; [@b19]). The identification of different prognostic factors may reflect the experience of different centers, but may be also biased by confounding factors. Prognosis of patients with embolism was previously described ([@b1]), but we are not aware of any study of prognostic factors in patients with acute limb ischemia secondary to thrombosis or embolism treated surgically in our country. In this study, we compared the risk profile of patients with thrombosis and embolism, and investigated prognostic factors for death or amputation in patients with acute limb ischemia classified in stages II and III of severity ([@b18]).

Methods
=======

A prospectively planned cohort study was carried out in a tertiary care regional hospital through a prospective registry format. Patients were referred from provincial hospitals or were seeking assistance directly in our hospital. The comprising cohort of patients was from a region with approximately one million inhabitants. All patients with acute limb ischemia, secondary to thrombosis, embolism, or trauma, were screened. Acute limb ischemia was characterized as a quick or sudden decrease in limb perfusion, producing new or worsening symptoms, and signs of threatening limb viability. Patients with embolism or thrombosis in categories II and III of severity, and submitted to surgical revascularization or primary amputation, were enrolled in the study. The categories of acute limb ischemia were classified according to the protocol of [@b18].

The protocol included assessment of anthropometric and demographic data, comorbidities and risk factors, duration of occlusion, and type of surgery. Hypertension, hypercholesterolemia, and diabetes were characterized by history or use of blood pressure-lowering drugs, hypolipemiant, or antidiabetic drugs. Past (time of quitting not specified) and current smokers were classified as smokers. Coronary heart disease was diagnosed in the presence of a history of a previous myocardial infarction, angina or a "Q" wave in the electrocardiogram. Atrial fibrillation was diagnosed by an electrocardiogram taken during the acute vascular episode. The diagnosis of stroke was based on history or evidence of motor deficit. Previous peripheral artery disease was characterized by history of intermittent claudication. Renal insufficiency was defined by creatinine over 3.0 mg per deciliter or hemodialysis. Duration of occlusion was estimated by the time between the onset symptoms of acute limb ischemia (first symptoms) and the arrival in the emergency room of our hospital. The American Society of Anesthesiologists (ASA) risk category was used by the anesthesiologist for the purpose of classification.

Six vascular surgeons, all with 3--5 years of training in medical residency, and with at least 5 years of experience, performed all surgeries.

The primary outcome was the occurrence of death or amputation in 30 days and 1 year. These events were analyzed separately as secondary outcomes. The occurrence of death or amputation by several prognostic characteristics was tested by the Chi square test. Student\'s t-test was employed to test for differences in continuous variables between patients with thrombosis and embolism. Logistic regression models were used to explore the relationship between prognostic factors for amputation or death in 30 days. A Cox proportional hazard model was used to explore these associations during the follow-up of 1-year, including time-to-event as covariate.

The study was approved by the Ethical Committee of our Institution. We ensured the anonymous identification of the participants.

Results
=======

In total, 83 sequential patients with acute limb ischemia classified in the Rutherford categories II and III (16 in category III) of severity, were enrolled between 1997 and 2000. The cohort was followed for 1 month and 3 were lost after this period in the follow-up to one year. The main cause of limb ischemia in this cohort was thrombosis (56.6%) with the remaining cause being due to emboli (43.4%). The demographics of patients studied are presented in [Table 1](#tbl1){ref-type="table"}. It is evident that patients with thrombosis were more frequently male and smokers. Comorbidities were also more frequent among patients with thrombosis, with the exception of atrial fibrillation, which was more common among patients with embolism. Only 1 patient with embolism and 2 with thrombosis were submitted to duplex scanning. Angiography was done in 5 (13.9%) of the patients with embolism and in 23 (48.9%) of the patients with thrombosis (p \< 0.001). Fasciotomy was done in 6 (16.7%) of the patients with embolism and in 1 (2.1%) of the patients with thrombosis (p = 0.039). The level of occlusion is presented in [Table 2](#tbl2){ref-type="table"} and the surgical procedures employed in the management of these cases are presented in [Table 3](#tbl3){ref-type="table"}. Occlusion at the level of superficial femoral artery accounted for almost 50% of the cases of embolism and thrombosis. In patients with embolism, the common femoral artery was the second site of occlusion, while in patients with thrombosis the external iliac artery was the second site of occlusion. Almost all patients with embolism were treated by thromboembolectomy, while the cases of thrombosis were managed with bypass using venous and artificial grafts and endarterectomy. Endovascular therapy and thrombolysis were not in use at the time of data collection. Only patients with thrombosis were submitted to primary amputation (19.1%).

###### 

Demographics of population of patients with limb ischemia that were studied (mean ± SD or n (%) within stratum)

  Characteristics               Embolism (n = 36)   Thrombosis (n = 47)   p
  ----------------------------- ------------------- --------------------- ---------
  Age (y)                       67 ± 12             69 ± 10               NS
  Male gender                   12 (33.3)           36 (76.6)             \<0.001
  Previous vascular procedure   9 (25)              13 (27.7)             NS
  Duration of occlusion (h)     38 ± 79             41 ± 46               NS
  Smoking                       10 (27.8)           40 (85.1)             \<0.001
  Diabetes mellitus             7 (19.4)            20 (42.6)             0.034
  Hypertension                  15 (41.7)           17 (36.2)             NS
  Coronary artery disease       14 (38.9)           22 (46.8)             NS
  Cerebral vascular disease     0                   7 (14.9)              0.017
  Peripheral vascular disease   6 (16.7)            35 (74.5)             \<0.001
  Hyperlipidemia                7 (19.4)            1 (2.1)               0.019
  Atrial fibrillation           20 (55.6)           11 (23.4)             0.003
  Renal insufficiency           1 (2.8)             1 (2.1)               NS
  ASA                           2.89 ± 0.46         2.83 ± 0.67           NS

**Abbreviations:** ASA, American Society of Anesthesiologists classification; h, hours; y, years.

###### 

Level of occlusion in participants classified by the cause of limb ischemia (n and %)

  Site                   Embolism (n = 36)   Thrombosis (n = 47)
  ---------------------- ------------------- ---------------------
  Infrarenal aorta       2 (5.6)             6 (12.8)
  Common iliac           3 (8.3)             3 (6.4)
  External iliac         4 (11.1)            8 (17.0)
  Common femoral         6 (16.7)            1 (2.1)
  Superficial femoral    14 (38.8)           19 (40.4)
  Popliteal above-knee   5 (13.9)            6 (12.8)
  Popliteal below-knee   0                   4 (8.5)
  Posterior tibial       2 (5.6)             0

###### 

Type of surgical procedures to deal with limb ischemia (n and %)

  Procedure               Embolism (n = 36)   Thrombosis (n = 47)
  ----------------------- ------------------- ---------------------
  Thromboembolectomy      35 (97.2)           1 (2.1)
  Bypass in situ GSV                          10 (21.3)
  Bypass reversed GSV                         6 (12.8)
  Bypass PTFE or Dacron   1 (2.8)             13 (27.7)
  Primary amputation                          9 (19.1)
  Endarterectomy                              7 (14.9)
  Composite bypass                            1 (2.1)

**Abbreviations:** GSV, greater saphenous vein; PTFE, polytetrafluoroethylene.

There were 15 (18.1%) deaths and 24 (28.9%) amputations in the cohort of patients investigated. The incidence of amputation or death according to the presence of prognostic factors is presented in [Table 4](#tbl4){ref-type="table"}. Duration of occlusion was one characteristic associated with a poor prognosis while the presence of diabetes showed a trend for poor prognosis. These associations persisted in a logistic regression model that included themselves with age, gender, hypertension, and cause of occlusion as explanatory variables ([Table 5](#tbl5){ref-type="table"}). The same trends persisted during the follow-up of one year, adjusting for the same set of confounding variables. The hazard ratio for death or amputation for duration of occlusion longer than 24 hours was 1.7 (95% confidence interval \[CI\] 0.9--3.3). For diabetes the hazard ratio was 1.6 (95% CI 0.8--2.9). Three cases were censored at 1-month of follow-up.

###### 

Incidence of amputation or death by baseline characteristics, duration of surgery, or cause of occlusion (n and %)

  Characteristics               Condition (n)     Amputation or death   p
  ----------------------------- ----------------- --------------------- -------
  Gender                        Female (35)       20 (57.1)             0.376
                                Male (48)         22 (45.8)             
  Age (y)                       \<65 (33)         15 (45.5)             0.505
                                \>65 (50)         27 (54.0)             
  Cause of occlusion            Thrombosis (47)   24 (51.1)             1.0
                                Embolism (36)     18 (50.5)             
  Atrial fibrillation           Yes (31)          16 (51.6)             1.0
                                No (52)           26 (50.0)             
  Cerebral vascular disease     Yes (7)           4 (57.1)              1.0
                                No (76)           38 (50.0)             
  Coronary artery disease       Yes (36)          21 (58.3)             0.270
                                No (47)           21 (44.7)             
  Diabetes mellitus             Yes (27)          18 (66.7)             0.061
                                No (56)           24 (42.9)             
  Smoking                       Yes (50)          23 (46.0)             0.372
                                No (33)           19 (57.6)             
  Duration of occlusion (h)     \>24 (42)         26 (63.4)             0.028
                                \<24 (41)         16 (38.1)             
  Hypertension                  Yes (32)          17 (53.1)             0.822
                                No (51)           25 (49.0)             
  Hyperlipidemia                Yes (8)           3 (37.5)              0.717
                                No (75)           39 (52.0)             
  Peripheral vascular disease   Yes (41)          21 (51.2)             1.0
                                No (42)           21 (50.0)             
  Angiography                   Yes (28)          11 (39.3)             0.168
                                No (55)           31 (56.4)             
  Level of occlusion            Proximal (33)     16 (48.5)             0.824
                                Distal (50)       26 (52.0)             

**Abbreviations:** h, hours; y, years.

###### 

Prognostic factors for death or amputation in 30 days as analyzed by logistic regression model

  Characteristics                             OR (95% Confidence interval)   p
  ------------------------------------------- ------------------------------ ------
  Female gender                               1.4 (0.5--4.3)                 0.39
  Age \> 65 (y)                               1.4 (0.5--3.8)                 0.53
  Duration of occlusion \> 24 (h)             2.6 (1.1--7.6)                 0.03
  Diabetes                                    2.6 (0.9--7.5)                 0.07
  Hypertension                                0.9 (0.4--2.5)                 0.92
  Embolism[\*](#tf5-1){ref-type="table-fn"}   1.4 (0.4--4.4)                 0.58

**Abbreviations:** h, hours; OR, odds ratio; y, years.

[note]{.smallcaps}: Adjusted for age, gender, duration of occlusion, diabetes, and cause of occlusion.

The control group was constituted by patients with thrombosis.

In the logistic regression models that included death and amputation separately as dependent variables, the odds ratios (OR) were among the 95% confidence estimates of the composite endpoint, and presented a similar trend for risk or protection. Hypertension showed a trend for protection against amputation (OR 0.3, CI 0.1--1.1 p = 0.06) but was associated with the risk of death (OR 3.7, CI 1.2--11.5, p = 0.03).

The level of occlusion, stratified in proximal (aorta, common iliac, external iliac, and common femoral artery) and distal (superficial femoral, popliteal, anterior and posterior tibial, and peroneal artery), was not associated with the incidence of death, amputation, or both.

The incidence of reperfusion injury (limb swelling with impaired muscle function with or without systemic manifestations) due to ischemia was 6.0%, being restricted to patients with embolism (13.9%). It was a risk factor for death, but not for amputation in these patients (OR 16.9, 95% CI 1.1--232.9, p = 0.04) after adjustment for age, duration of occlusion, and diabetes.

Discussion
==========

Thrombosis was more frequent than embolism as a cause of nontraumatic limb ischemia in our hospital. A higher proportion of embolism ([@b1]), thrombosis ([@b16]), and a similar frequency of both conditions ([@b8]) have been described. Patients with thrombosis were more frequently male and had higher prevalence of cardiovascular risk factors and comorbidities, such as a previous diagnosis of peripheral vascular disease and cerebrovascular disease. As expected, patients with embolism more often had atrial fibrillation ([@b4]).

The incidence of death or amputation was almost 50% as described in other centers ([@b2]; [@b13]; [@b20]; [@b3]). The independent risk factor for an unfavorable outcome was prolonged time between the beginning of symptoms and the surgery. Diabetes also showed a trend for such risk (ie, unfavorable outcome). These prognostic factors have been previously described ([@b2]; [@b21]; [@b19]). In the Basle study, it was reported that major amputations were 11 times more frequent in diabetic patients with peripheral arterial disease (PAD) than in nondiabetic PAD patients ([@b5]). Duration of occlusion was the most important modifiable cause of amputation or death in our cohort. We did not analyze specific causes for the long interval between the beginning of symptoms and the arrival at the emergency department. We speculate that the low level of education of most patients, their fear of doctors, and misdiagnosis may be underlying causes for such catastrophic behavior.

Hypertension showed a trend for protection against amputation but was significantly associated with a higher risk of death. Although [@b11] noted that the risk of deterioration was related to blood pressure, the study by [@b7] did not find a significant link between hypertension and prognosis after adjustment for other risk factors. Our findings may be ascribed to chance, but the possibility that higher blood pressure during such events protects against the failure of grafts needs to be further investigated in a systematic manner.

Cigarette smoking is a major risk for developing peripheral arterial disease ([@b12]; [@b5]), but we could not find any association between smoking that influenced the prognosis of acute limb ischemia. This risk factor deserves further investigation since our negative findings could be attributed to sample size and a lower statistical power of our study.

The incidence of reperfusion injury was restricted to patients with embolism and was a risk factor for death. This has been well recognized as a serious complication of revascularization ([@b19]).

In conclusion, acute limb ischemia caused by thrombosis or embolia was identified as a serious medical event in our hospital, being associated with high rates of mortality or amputation. In general, atherosclerotic vascular disease was a risk factor for thrombosis, while atrial fibrillation was a strong risk factor for embolism. It seems that the time interval for medical care and attention is one of the most important and modifiable prognostic factors for either death or amputation.
